Literature DB >> 20640409

Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.

Adam M Hawkridge1, Rebecca B Wysocky, James N Petitte, Kenneth E Anderson, Paul E Mozdziak, Oscar J Fletcher, Jonathan M Horowitz, David C Muddiman.   

Abstract

The domestic chicken (Gallus domesticus) has emerged as a powerful experimental model for studying the onset and progression of spontaneous epithelial ovarian cancer (EOC) with a disease prevalence that can exceed 35% between 2 and 7 years of age. An experimental strategy for biomarker discovery is reported herein that combines the chicken model of EOC, longitudinal plasma sample collection with matched tissues, advanced mass spectrometry-based proteomics, and concepts derived from the index of individuality (Harris, Clin Chem 20: 1535-1542, 1974). Blood was drawn from 148 age-matched chickens starting at 2.5 years of age every 3 months for 1 year. At the conclusion of the 1 year sample collection period, the 73 birds that remained alive were euthanized, necropsied, and tissues were collected. Pathological assessment of resected tissues from these 73 birds confirmed that five birds (6.8%) developed EOC. A proteomics workflow including in-gel digestion, nanoLC coupled to high-performance mass spectrometry, and label-free (spectral counting) quantification was used to measure the biological intra-individual variability (CV(W)) of the chicken plasma proteome. Longitudinal plasma sample sets from two birds within the 73-bird biorepository were selected for this study; one bird was considered "healthy" and the second bird developed late-stage EOC. A total of 116 proteins from un-depleted plasma were identified with 80 proteins shared among all sample sets. Analytical variability (CV(A)) of the label-free proteomics workflow was measured using a single plasma sample analyzed five times and was found to be ≥CV(W) in both birds for 16 proteins (20%) and in either bird for 25 proteins (31%). Ovomacroglobulin (ovostatin) was found to increase (p < 0.001) over a 6 month period in the late-stage EOC bird providing an initial candidate protein for further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640409      PMCID: PMC3140420          DOI: 10.1007/s00216-010-3979-y

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  89 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest.

Authors:  C S Spahr; M T Davis; M D McGinley; J H Robinson; E J Bures; J Beierle; J Mort; P L Courchesne; K Chen; R C Wahl; W Yu; R Luethy; S D Patterson
Journal:  Proteomics       Date:  2001-01       Impact factor: 3.984

3.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

4.  A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results.

Authors:  D Brent Weatherly; James A Atwood; Todd A Minning; Cameron Cavola; Rick L Tarleton; Ron Orlando
Journal:  Mol Cell Proteomics       Date:  2005-02-09       Impact factor: 5.911

5.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

Authors:  Sergei A Moshkovskii; Marina V Serebryakova; Konstantin B Kuteykin-Teplyakov; Olga V Tikhonova; Eugene I Goufman; Victor G Zgoda; Irina N Taranets; Oleg V Makarov; Alexander I Archakov
Journal:  Proteomics       Date:  2005-09       Impact factor: 3.984

7.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  Usha Menon; Aleksandra Gentry-Maharaj; Rachel Hallett; Andy Ryan; Matthew Burnell; Aarti Sharma; Sara Lewis; Susan Davies; Susan Philpott; Alberto Lopes; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Mourad W Seif; Ian Scott; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Nazar N Amso; Simon Leeson; Derek Cruickshank; Alistair McGuire; Stuart Campbell; Lesley Fallowfield; Naveena Singh; Anne Dawnay; Steven J Skates; Mahesh Parmar; Ian Jacobs
Journal:  Lancet Oncol       Date:  2009-03-11       Impact factor: 41.316

8.  The chicken egg white proteome.

Authors:  Karlheinz Mann
Journal:  Proteomics       Date:  2007-10       Impact factor: 3.984

9.  Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

Authors:  S J Skates; F J Xu; Y H Yu; K Sjövall; N Einhorn; Y Chang; R C Bast; R C Knapp
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

10.  Ovarian tumors of the hen.

Authors:  T N Fredrickson
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

View more
  15 in total

1.  Identification of glycoproteins containing specific glycans using a lectin-chemical method.

Authors:  Yan Li; Punit Shah; Angelo M De Marzo; Jennifer E Van Eyk; Qianqian Li; Daniel W Chan; Hui Zhang
Journal:  Anal Chem       Date:  2015-04-20       Impact factor: 6.986

2.  Dicer1, AGO3, and AGO4 microRNA machinery genes are differentially expressed in developing female reproductive organs and overexpressed in cancerous ovaries of chickens.

Authors:  W Jeong; H Bae; W Lim; G Song
Journal:  J Anim Sci       Date:  2017-11       Impact factor: 3.159

Review 3.  The chicken model of spontaneous ovarian cancer.

Authors:  Adam M Hawkridge
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

4.  The PeptideAtlas of the Domestic Laying Hen.

Authors:  James McCord; Zhi Sun; Eric W Deutsch; Robert L Moritz; David C Muddiman
Journal:  J Proteome Res       Date:  2017-02-14       Impact factor: 4.466

5.  A method to determine the kinetics of multiple proteins in human infants with respiratory distress syndrome.

Authors:  Michael S Bereman; Daniela M Tomazela; Hillary S Heins; Manuela Simonato; Paola E Cogo; Aaron Hamvas; Bruce W Patterson; F Sessions Cole; Michael J MacCoss
Journal:  Anal Bioanal Chem       Date:  2012-04-14       Impact factor: 4.142

6.  In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.

Authors:  Angelito I Nepomuceno; Huanjie Shao; Kai Jing; Yibao Ma; James N Petitte; Michael O Idowu; David C Muddiman; Xianjun Fang; Adam M Hawkridge
Journal:  Anal Bioanal Chem       Date:  2015-07-10       Impact factor: 4.142

7.  The hen as a model of ovarian cancer.

Authors:  Patricia A Johnson; James R Giles
Journal:  Nat Rev Cancer       Date:  2013-05-16       Impact factor: 60.716

8.  Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer model.

Authors:  Genna L Andrews Kingon; James N Petitte; David C Muddiman; Adam M Hawkridge
Journal:  Methods       Date:  2013-04-19       Impact factor: 3.608

9.  Towards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational research.

Authors:  Yingying Ma; Zeyu Sun; Ricardo de Matos; Jing Zhang; Kunle Odunsi; Biaoyang Lin
Journal:  OMICS       Date:  2014-03-24

10.  The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors.

Authors:  Yi Yu; Seby L Edassery; Animesh Barua; Jacques S Abramowicz; Janice M Bahr; Ingegerd Hellstrom; Judith L Luborsky
Journal:  J Ovarian Res       Date:  2011-07-29       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.